moxalactam has been researched along with Cross Infection in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (82.35) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Beaucaire, G; Caillaux, M; Deboscker, Y; Fourrier, A; Mouton, Y | 1 |
| Ernest, KD; Magnussen, CR; Sammartino, MT | 1 |
| Pranada, F; Pusztai-Markos, Z | 1 |
| Bergogne-Berezin, E; Chabbert, YA; Cluzel, R; Courtieu, AL; Dabernat, H; Deforges, L; Duval, J; Witchitz, JL | 1 |
| Acar, JF | 1 |
| Bismuth, R; Grosset, J; Jarlier, V | 1 |
| Bryskier, A; Le Noc, D; Le Noc, P | 1 |
| Acar, JF; Bure, A; Christol, D; Courtieu, AL; Dabernat, H; Deforges, L; Duval, J; Kitzis, D; Le Van Thoi, J; Soussy, CJ | 1 |
| Pedler, SJ | 1 |
| Smith, AL | 1 |
| Baquero, F; Canton, R; Gomez-Alferez, A; Loza, E; Martinez-Beltran, J | 1 |
| Cassady, G; Knight, P | 1 |
| Durgham, SM; Ishag, AH; Shibl, AM | 1 |
| Follath, F; Mall, T; Reber, H; Ritz, R; Salfinger, M | 1 |
| Citron, DM; Goldstein, EJ | 1 |
| Waldvogel, FA | 1 |
1 review(s) available for moxalactam and Cross Infection
| Article | Year |
|---|---|
Neonatal bacterial infection.
Topics: Antigens; B-Lymphocytes; Bacterial Infections; Chemotaxis, Leukocyte; Complement System Proteins; Cross Infection; Digestive System; Escherichia coli Infections; Female; Gram-Negative Bacteria; Humans; Immunoglobulin G; Immunoglobulin M; Infant, Newborn; Maternal-Fetal Exchange; Meningitis; Methicillin; Moxalactam; Neutrophils; Penicillin G; Permeability; Phagocytosis; Pregnancy; Sepsis; Streptococcal Infections; T-Lymphocytes | 1982 |
1 trial(s) available for moxalactam and Cross Infection
| Article | Year |
|---|---|
[Clinical evaluation of moxalactam].
Topics: Bacterial Infections; Cephalosporins; Cephamycins; Clinical Trials as Topic; Critical Care; Cross Infection; Humans; Meningitis; Moxalactam; Sepsis; Urinary Tract Infections | 1983 |
15 other study(ies) available for moxalactam and Cross Infection
| Article | Year |
|---|---|
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
[Use of moxalactam in intensive care units: clinical and bacteriological results related to serum and bronchial concentrations ].
Topics: Adult; Aged; Cephalosporins; Cephamycins; Critical Care; Cross Infection; Female; Humans; Male; Middle Aged; Moxalactam; Respiratory Tract Infections; Sepsis; Sputum | 1982 |
Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Cross Infection; Humans; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin | 1982 |
In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
Topics: Acinetobacter; Bacteria; Cefotaxime; Cephalosporins; Cephamycins; Cross Infection; Drug Resistance, Microbial; Enterobacter; Escherichia coli; Gentamicins; Imipenem; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia; Thienamycins | 1982 |
[In vitro action of moxalactam on hospital bacteria. Results of a multicenter survey].
Topics: Bacteria; Bacteroides fragilis; Cephalosporins; Cephamycins; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Haemophilus; Humans; Microbial Sensitivity Tests; Moxalactam; Staphylococcus; Streptococcus | 1983 |
[Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams].
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Moxalactam; Phenotype | 1983 |
[In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
Topics: Anti-Bacterial Agents; Bacteria; Cefmenoxime; Cefotaxime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Moxalactam | 1983 |
[In vitro activity of cefatiolene (RP 42,980) against hospital bacteria. Comparison with cefotaxime and lamoxactam. Results of a multicenter study].
Topics: Bacteria; Cefotaxime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Moxalactam; Staphylococcus aureus | 1983 |
The activity in vitro of ceftazidime (GR 20263) and moxalactam (LY 127935) against Gram-negative bacteria from hospital patients.
Topics: Bacteria; Ceftazidime; Cephalosporins; Cephamycins; Cross Infection; Humans; Microbial Sensitivity Tests; Moxalactam | 1981 |
The incidence and beta-lactam resistance of Proteus vulgaris in hospital infections: the last decade.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Aztreonam; Bacteremia; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Moxalactam; Penicillins; Phenotype; Proteus Infections; Proteus vulgaris; Spain; Urinary Tract Infections | 1991 |
Control of infection due to Klebsiella pneumoniae in an intensive care nursery.
Topics: Alabama; Cephalexin; Cohort Studies; Cross Infection; Disease Outbreaks; Enterocolitis, Pseudomembranous; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Moxalactam; Nurseries, Hospital; Nursing Staff, Hospital; Serotyping | 1990 |
Comparative in vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
Topics: Aztreonam; Cefoperazone; Cefotaxime; Ceftazidime; Cross Infection; Gentamicins; Gram-Negative Bacteria; Moxalactam; Ticarcillin | 1989 |
Moxalactam in nosocomial infections with Serratia marcescens.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Moxalactam; Serratia marcescens | 1985 |
Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals.
Topics: Bacteria, Anaerobic; Cefoxitin; Cephamycins; Clindamycin; Cross Infection; Hospitals, Community; Humans; Microbial Sensitivity Tests; Moxalactam; Piperacillin | 1985 |
Third generation cephalosporins--a panacea for intensive care patients?
Topics: Bacterial Infections; Cephalosporins; Cross Infection; Humans; Intensive Care Units; Moxalactam | 1985 |